12 | 13 | | A BILL TO BE ENTITLED 1 |
---|
13 | 14 | | AN ACT TO UPDATE THE CONTROLLED SUBSTANCES ACT. 2 |
---|
14 | 15 | | The General Assembly of North Carolina enacts: 3 |
---|
15 | 16 | | SECTION 1.(a) G.S. 90-89(1) reads as rewritten: 4 |
---|
16 | 17 | | "(1) Opiates. – Any of the following opiates or opioids, including the isomers, 5 |
---|
17 | 18 | | esters, ethers, salts and salts of isomers, esters, and ethers, unless specifically 6 |
---|
18 | 19 | | excepted, or listed in another schedule, whenever the existence of such 7 |
---|
19 | 20 | | isomers, esters, ethers, and salts is possible within the specific chemical 8 |
---|
20 | 21 | | designation: 9 |
---|
21 | 22 | | … 10 |
---|
22 | 23 | | sss. AP-237. 11 |
---|
23 | 24 | | ttt. 2-methyl AP-237. 12 |
---|
24 | 25 | | uuu. (ortho, meta, or para)-methyl AP-237. 13 |
---|
25 | 26 | | vvv. AP-238. 14 |
---|
26 | 27 | | www. (ortho, meta, or para)-hydroxy 2-methyl AP-237. 15 |
---|
27 | 28 | | xxx. 2-Naphthyl U-47700. 16 |
---|
28 | 29 | | yyy. 1-Naphthyl U-47700. 17 |
---|
29 | 30 | | zzz. 4-(Trifluoromethyl) U-47700. 18 |
---|
30 | 31 | | aaaa. Methoxy U-47700. 19 |
---|
31 | 32 | | bbbb. Furanyl UF-17. 20 |
---|
32 | 33 | | cccc. Cyclopropyl U-47700. 21 |
---|
33 | 34 | | dddd. Phenyl U-47700. 22 |
---|
34 | 35 | | eeee. Ethyl U-47700. 23 |
---|
35 | 36 | | ffff. (2,3- or 3,4)-difluoro-N,N-didesmethyl U-47700. 24 |
---|
36 | 37 | | gggg. (2,3- or 3,4)-difluoro U-49900. 25 |
---|
37 | 38 | | hhhh. (2,3- or 3,4)-difluoro-N-desmethyl U-47700. 26 |
---|
38 | 39 | | iiii. 4-fluoro U-47931E. 27 |
---|
39 | 40 | | jjjj. (2,3- or 3,4)-difluoro U-51754. 28 |
---|
40 | 41 | | kkkk. (2,3- or 3,4)-difluoro Isopropyl U-47700. 29 |
---|
41 | 42 | | llll. (2,3- or 3,4)-difluoro Propyl U-47700. 30 |
---|
42 | 43 | | mmmm. (2,3- or 3,4)-difluoro U-50488. 31 |
---|
43 | 44 | | nnnn. (2,3- or 3,4)-difluoro U-48800. 32 |
---|
44 | 45 | | oooo. (2,3- or 3,4 or 2,4)-difluoro U-47700. 33 |
---|
45 | 46 | | pppp. UF-17. 34 |
---|
46 | 47 | | qqqq. U-47109. 35 |
---|
49 | 54 | | ssss. N,N-didesmethyl U-47700. 1 |
---|
50 | 55 | | tttt. U-62066. 2 |
---|
51 | 56 | | uuuu. Propyl U-47700. 3 |
---|
52 | 57 | | vvvv. (2,3- or 3,4)-Ethylenedioxy U-51754. 4 |
---|
53 | 58 | | wwww. 4-phenyl U-51754. 5 |
---|
54 | 59 | | xxxx. N-desmethyl U-47700. 6 |
---|
55 | 60 | | yyyy. (2,3- or 3,4)-Ethylenedioxy U-47700. 7 |
---|
56 | 61 | | zzzz. N-methyl U-47931E. 8 |
---|
57 | 62 | | aaaaa. (2,3- or 3,4)-Methylenedioxy U-47700. 9 |
---|
58 | 63 | | bbbbb. U-69593. 10 |
---|
59 | 64 | | ccccc. U-50488. 11 |
---|
60 | 65 | | ddddd. U-48753E. 12 |
---|
61 | 66 | | eeeee. U-47931E." 13 |
---|
62 | 67 | | SECTION 1.(b) G.S. 90-89(1a) reads as rewritten: 14 |
---|
63 | 68 | | "(1a) Fentanyl derivatives. – Unless specifically excepted, listed in another 15 |
---|
64 | 69 | | schedule, or contained within a pharmaceutical product approved by the 16 |
---|
65 | 70 | | United States Food and Drug Administration, any compound structurally 17 |
---|
66 | 71 | | derived from N-[1-(2-phenylethyl)-4-piperidinyl]-N-phenylpropanamide 18 |
---|
67 | 72 | | (Fentanyl) by any substitution on or replacement of the phenethyl group, any 19 |
---|
68 | 73 | | substitution on the piperidine ring, any substitution on or replacement of the 20 |
---|
69 | 74 | | propanamide group, any substitution on the anilido phenyl group, or any 21 |
---|
70 | 75 | | combination of the above unless specifically excepted or listed in another 22 |
---|
71 | 76 | | schedule to include their salts, isomers, and salts of isomers. Fentanyl 23 |
---|
72 | 77 | | derivatives include, but are not limited to, the following: 24 |
---|
73 | 78 | | … 25 |
---|
74 | 79 | | f.26 |
---|
75 | 80 | | N-(2-fluorophenyl)-N-[1-(2-phenylethyl)-4-piperidinyl]-propana27 |
---|
76 | 81 | | mide (also known as 2-fluorofentanyl).(also known as 28 |
---|
77 | 82 | | ortho-fluorofentanyl). 29 |
---|
78 | 83 | | g.30 |
---|
79 | 84 | | N-(3-fluorophenyl)-N-[1-(2-phenylethyl)-4-piperidinyl]-propana31 |
---|
80 | 85 | | mide (also known as 3-fluorofentanyl).(also known as 32 |
---|
81 | 86 | | meta-fluorofentanyl). 33 |
---|
82 | 87 | | … 34 |
---|
83 | 88 | | i.35 |
---|
84 | 89 | | N-(4-fluorophenyl)-2-methyl-N-[1-(2-phenylethyl)-4-piperidinyl]36 |
---|
85 | 90 | | -propanamide (also known as 4-fluoroisobutyryl fentanyl, 37 |
---|
86 | 91 | | 4-FIBF).(also known as 4-fluoroisobutyryl fentanyl). 38 |
---|
87 | 92 | | j. N-(4-fluorophenyl)-N-[1-(2-phenylethyl)-4-piperidinyl]-butanamide 39 |
---|
88 | 93 | | (also known as 4-fluorobutyryl fentanyl, 4-FBF).(also known as 40 |
---|
89 | 94 | | para-fluorobutyryl fentanyl)." 41 |
---|
90 | 95 | | SECTION 1.(c) G.S. 90-89 is amended by adding a new subdivision to read: 42 |
---|
91 | 96 | | "(1b) Nitazene derivatives. – The N-substituted benzimidazole structural class, 43 |
---|
92 | 97 | | including any of the following derivatives, their salts, isomers, or salts of 44 |
---|
93 | 98 | | isomers unless specifically utilized as part of the manufacturing process by a 45 |
---|
94 | 99 | | commercial industry of a substance or material not intended for human 46 |
---|
95 | 100 | | ingestion or consumption, as a prescription administered under medical 47 |
---|
96 | 101 | | supervision, or for research at a recognized institution, whenever the existence 48 |
---|
97 | 102 | | of these salts, isomers, or salts of isomers is possible within the specific 49 |
---|
98 | 103 | | chemical designation or unless specifically excepted or listed in this or another 50 |
---|
99 | 104 | | schedule, structurally derived from benzimidazole by substitution at the 51 General Assembly Of North Carolina Session 2025 |
---|
101 | 106 | | 1-position nitrogen with an ethylamine group, and by substitution at the 1 |
---|
102 | 107 | | 2-position carbon with a benzyl group, whether or not the compound is further 2 |
---|
103 | 108 | | modified in any of the following ways: 3 |
---|
104 | 109 | | a. By monoalkyl or dialkyl substitution on the 1'-nitrogen of the 4 |
---|
105 | 110 | | 1-position ethylamine group, or by inclusion of the nitrogen in a cyclic 5 |
---|
106 | 111 | | structure. 6 |
---|
107 | 112 | | b. By substitution on the 2'-methylene carbon of the benzyl group by 7 |
---|
108 | 113 | | alkyl or carboxamide groups. 8 |
---|
109 | 114 | | c. By replacement of the 2'-methylene carbon group with an ethylbenzyl, 9 |
---|
110 | 115 | | thiophenol, or methoxybenzene group, which may be further 10 |
---|
111 | 116 | | substituted with alkyl, hydroxyl, alkoxy, acetoxy, halide, or sulfide 11 |
---|
112 | 117 | | groups. 12 |
---|
113 | 118 | | d. By substitution at the 2'-position, 3'-position, or 4'-position of the 13 |
---|
114 | 119 | | benzyl group, or both, with alkyl, hydroxyl, alkoxy, acetoxy, halide, 14 |
---|
115 | 120 | | or sulfide groups. 15 |
---|
116 | 121 | | e. By replacement of a phenyl hydrogen atom at either the 5-position or 16 |
---|
117 | 122 | | 6-position of the benzimidazole core with a nitro, or primary amine 17 |
---|
118 | 123 | | group." 18 |
---|
119 | 124 | | SECTION 1.(d) G.S. 90-89(3)mm. reads as rewritten: 19 |
---|
120 | 125 | | "mm. 5-methoxy-N-methyl-N-propyltryptamine 20 |
---|
121 | 126 | | (5-MeO-MiPT).5-methoxy-N-methyl-N-isopropyltryptamine 21 |
---|
122 | 127 | | (5-MeO-MiPT)." 22 |
---|
123 | 128 | | SECTION 1.(e) G.S. 90-89(4) is amended by adding a new sub-subdivision to read: 23 |
---|
124 | 129 | | "j. Bromazolam." 24 |
---|
125 | 130 | | SECTION 1.(f) G.S. 90-89(5)j. reads as rewritten: 25 |
---|
126 | 131 | | "j. Substituted cathinones. A compound, other than bupropion, that is 26 |
---|
127 | 132 | | structurally derived from 2-amino-1-phenyl-1-propanone by 27 |
---|
128 | 133 | | modification in any of the following ways: (i) by substitution in the 28 |
---|
129 | 134 | | phenyl ring to any extent with alkyl, alkoxy, alkylenedioxy, haloalkyl, 29 |
---|
130 | 135 | | or halide substituents, whether or not further substituted in the phenyl 30 |
---|
131 | 136 | | ring by one or more other univalent substituents; (ii) by substitution at 31 |
---|
132 | 137 | | the 3-position to any extent; or (iii) by substitution at the nitrogen atom 32 |
---|
133 | 138 | | with alkyl, dialkyl, benzyl, cycloalkyl, or methoxybenzyl groups or by 33 |
---|
134 | 139 | | inclusion of the nitrogen atom in a cyclic structure. For the purpose of 34 |
---|
135 | 140 | | this paragraph, the term "isomer" includes the optical, positional, or 35 |
---|
136 | 141 | | geometric isomer." 36 |
---|
137 | 142 | | SECTION 1.(g) G.S. 90-89(7) reads as rewritten: 37 |
---|
138 | 143 | | "(7) Synthetic cannabinoids. – Any quantity of any synthetic chemical compound 38 |
---|
139 | 144 | | that (i) is a cannabinoid receptor agonist and mimics the pharmacological 39 |
---|
140 | 145 | | effect of naturally occurring substances or (ii) has a stimulant, depressant, or 40 |
---|
141 | 146 | | hallucinogenic effect on the central nervous system that is not listed as a 41 |
---|
142 | 147 | | controlled substance in Schedules I through V, and is not an FDA-approved 42 |
---|
143 | 148 | | drug. Synthetic cannabinoids include, but are not limited to, the substances 43 |
---|
144 | 149 | | listed in sub-subdivisions a. through p. v. of this subdivision and any substance 44 |
---|
145 | 150 | | that contains any quantity of their salts, isomers (whether optical, positional, 45 |
---|
146 | 151 | | or geometric), homologues, and salts of isomers and homologues, unless 46 |
---|
147 | 152 | | specifically excepted, whenever the existence of these salts, isomers, 47 |
---|
148 | 153 | | homologues, and salts of isomers and homologues is possible within the 48 |
---|
149 | 154 | | specific chemical designation. The following substances are examples of 49 |
---|
150 | 155 | | synthetic cannabinoids and are not intended to be inclusive of the substances 50 |
---|
151 | 156 | | included in this Schedule: 51 General Assembly Of North Carolina Session 2025 |
---|
153 | 158 | | … 1 |
---|
154 | 159 | | l. Indole carboxamides. Any compound structurally derived from 2 |
---|
155 | 160 | | 1H-indole-3-carboxamide or 1H-indole-2-carboxamide substituted in 3 |
---|
156 | 161 | | one or both of the following ways: 4 |
---|
157 | 162 | | 1. At the nitrogen atom of the indole ring by an alkyl, haloalkyl, 5 |
---|
158 | 163 | | cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 6 |
---|
159 | 164 | | 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 7 |
---|
160 | 165 | | 1-(N-methyl-2-pyrrolidinyl)methyl, 8 |
---|
161 | 166 | | 1-(N-methyl-3-morpholinyl)methyl, tetrahydropyranylmethyl, 9 |
---|
162 | 167 | | benzyl, or halo benzyl group; andor 10 |
---|
163 | 168 | | 2. At the nitrogen of the carboxamide by a phenyl, benzyl, 11 |
---|
164 | 169 | | naphthyl, adamantyl, cyclopropyl, or propionaldehyde 12 |
---|
165 | 170 | | group;group, or methyl 3,3-dimethyl-butanoate group; 13 |
---|
166 | 171 | | whether or not the compound is further modified to any extent 14 |
---|
167 | 172 | | in the following ways: (i) substitution to the indole ring to any 15 |
---|
168 | 173 | | extent, (ii) substitution to the phenyl, benzyl, naphthyl, 16 |
---|
169 | 174 | | adamantyl, cyclopropyl, or propionaldehyde group to any 17 |
---|
170 | 175 | | extent, (iii) a nitrogen heterocyclic analog of the indole ring, or 18 |
---|
171 | 176 | | (iv) a nitrogen heterocyclic analog of the phenyl, benzyl, 19 |
---|
172 | 177 | | naphthyl, adamantyl, or cyclopropyl ring. Substances in this 20 |
---|
173 | 178 | | class include, but are not limited to: SDB-001 and 21 |
---|
174 | 179 | | STS-135.STS-135 and MDMB-ICA. 22 |
---|
175 | 180 | | … 23 |
---|
176 | 181 | | n. Indazole carboxaldehydes. Any compound structurally derived from 24 |
---|
177 | 182 | | 1H-indazole-3-carboxaldehyde or 1H-indazole-2-carboxaldehyde 25 |
---|
178 | 183 | | substituted in both of the following ways: 26 |
---|
179 | 184 | | … 27 |
---|
180 | 185 | | 2. At the carbon of the carboxaldehyde by a phenyl, benzyl, 28 |
---|
181 | 186 | | naphthyl, adamantyl, cyclopropyl, or propionaldehyde group; 29 |
---|
182 | 187 | | whether or not the compound is further modified to any extent 30 |
---|
183 | 188 | | in the following ways: (i) substitution to the indazole ring to 31 |
---|
184 | 189 | | any extent, (ii) substitution to the phenyl, benzyl, naphthyl, 32 |
---|
185 | 190 | | adamantyl, cyclopropyl, or propionaldehyde group to any 33 |
---|
186 | 191 | | extent, (iii) a nitrogen heterocyclic analog of the indazole ring, 34 |
---|
187 | 192 | | or (iv) a nitrogen heterocyclic analog of the phenyl, benzyl, 35 |
---|
188 | 193 | | naphthyl, adamantyl, or cyclopropyl ring. 36 |
---|
189 | 194 | | o. Indazole carboxamides. Any compound structurally derived from 37 |
---|
190 | 195 | | 1H-indazole-3-carboxamide or 1H -indazole-2-carboxamide 38 |
---|
191 | 196 | | substituted in one or both of the following ways: 39 |
---|
192 | 197 | | 1. At the nitrogen atom of the indazole ring by an alkyl, haloalkyl, 40 |
---|
193 | 198 | | cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 41 |
---|
194 | 199 | | 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 42 |
---|
195 | 200 | | 1-(N-methyl-2-pyrrolidinyl)methyl, 43 |
---|
196 | 201 | | 1-(N-methyl-3-morpholinyl)methyl, tetrahydropyranylmethyl, 44 |
---|
197 | 202 | | benzyl, or halo benzyl group; andor 45 |
---|
198 | 203 | | 2. At the nitrogen of the carboxamide by a phenyl, benzyl, 46 |
---|
199 | 204 | | naphthyl, adamantyl, cyclopropyl, or propionaldehyde 47 |
---|
200 | 205 | | group;group, or methyl 3,3-dimethyl-butanoate group; 48 |
---|
201 | 206 | | whether or not the compound is further modified to any extent 49 |
---|
202 | 207 | | in the following ways: (i) substitution to the indazole ring to 50 |
---|
203 | 208 | | any extent, (ii) substitution to the phenyl, benzyl, naphthyl, 51 General Assembly Of North Carolina Session 2025 |
---|
205 | 210 | | adamantyl, cyclopropyl, or propionaldehyde group to any 1 |
---|
206 | 211 | | extent, (iii) a nitrogen heterocyclic analog of the indazole ring, 2 |
---|
207 | 212 | | or (iv) a nitrogen heterocyclic analog of the phenyl, benzyl, 3 |
---|
208 | 213 | | naphthyl, adamantyl, or cyclopropyl ring. Substances in this 4 |
---|
209 | 214 | | class include, but are not limited to: AKB-48, fluoro-AKB-48, 5 |
---|
210 | 215 | | APINCACA, AB-PINACA, AB -FUBINACA, 6 |
---|
211 | 216 | | ADB-FUBINACA, and ADB-PINACA.ADB-PINACA, 7 |
---|
212 | 217 | | ADB-INACA, MDMB-INACA, MDMB-5Me-INACA, and 8 |
---|
213 | 218 | | MDMB-5Br-INACA. 9 |
---|
214 | 219 | | … 10 |
---|
215 | 220 | | s. Oxindoles. Any compound structurally derived from 11 |
---|
216 | 221 | | 3-hydrazonoindolin-2-one substituted in one or both of the following 12 |
---|
217 | 222 | | ways: 13 |
---|
218 | 223 | | 1. At the nitrogen atom of the oxoindole ring by an alkyl, 14 |
---|
219 | 224 | | haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, 15 |
---|
220 | 225 | | cycloalkylethyl; or 16 |
---|
221 | 226 | | 2. At the nitrogen of the hydrazide by a phenyl, benzyl, naphthyl, 17 |
---|
222 | 227 | | adamantyl, cyclopropyl, or propionaldehyde group; whether or 18 |
---|
223 | 228 | | not the compound is further modified to any extent in the 19 |
---|
224 | 229 | | following ways: (i) substitution to the oxoindole ring to any 20 |
---|
225 | 230 | | extent or (ii) substitution to the phenyl, benzyl, naphthyl, 21 |
---|
226 | 231 | | adamantyl, cyclopropyl, or propionaldehyde group to any 22 |
---|
227 | 232 | | extent. Substances in this class include, but are not limited to: 23 |
---|
228 | 233 | | BZO-POXIZID, BZO-HEXOXIZIDE, 5F-BZO-POXIZIDE. 24 |
---|
229 | 234 | | t. Indole acetamides. Any compound structurally derived from 25 |
---|
230 | 235 | | 1H-indole-3-acetamide or 1H-indole-2-acetamide substituted in one or 26 |
---|
231 | 236 | | both of the following ways: 27 |
---|
232 | 237 | | 1. At the nitrogen atom of the indole ring by an alkyl, haloalkyl, 28 |
---|
233 | 238 | | cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 29 |
---|
234 | 239 | | 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 30 |
---|
235 | 240 | | 1-(N-methyl-2-pyrrolidinyl)methyl, 31 |
---|
236 | 241 | | 1-(N-methyl-3-morpholinyl)methyl, tetrahydropyranylmethyl, 32 |
---|
237 | 242 | | benzyl, or halo benzyl group; or 33 |
---|
238 | 243 | | 2. At the nitrogen of the acetamide by a phenyl, benzyl, naphthyl, 34 |
---|
239 | 244 | | adamantyl, cyclopropyl, or propionaldehyde group; whether or 35 |
---|
240 | 245 | | not the compound is further modified to any extent in the 36 |
---|
241 | 246 | | following ways: (i) substitution to the indole ring to any extent, 37 |
---|
242 | 247 | | (ii) substitution to the phenyl, benzyl, naphthyl, adamantyl, 38 |
---|
243 | 248 | | cyclopropyl, or propionaldehyde group to any extent, (iii) a 39 |
---|
244 | 249 | | nitrogen heterocyclic analog of the indole ring, or (iv) a 40 |
---|
245 | 250 | | nitrogen heterocyclic analog of the phenyl, benzyl, naphthyl, 41 |
---|
246 | 251 | | adamantyl, or cyclopropyl ring. Substances in this class 42 |
---|
247 | 252 | | include, but are not limited to: AFUBIATA, CH-PIATA, 43 |
---|
248 | 253 | | AB-CHMIATA, ADB-FUBIATA. 44 |
---|
249 | 254 | | u. Indazole acetaldehydes. Any compound structurally derived from 45 |
---|
250 | 255 | | 1H-indazol-3-ylacetaldehyde or 1H-indazol-2-ylacetaldehyde 46 |
---|
251 | 256 | | substituted in one or both of the following ways: 47 |
---|
252 | 257 | | 1. At the nitrogen atom of the indazole ring by an alkyl, haloalkyl, 48 |
---|
253 | 258 | | cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 49 |
---|
254 | 259 | | 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 50 |
---|
255 | 260 | | 1-(N-methyl-2-pyrrolidinyl)methyl, 51 General Assembly Of North Carolina Session 2025 |
---|
257 | 262 | | 1-(N-methyl-3-morpholinyl)methyl, tetrahydropyranylmethyl, 1 |
---|
258 | 263 | | benzyl, or halo benzyl group; or 2 |
---|
259 | 264 | | 2. At the nitrogen of the carboxamide by a phenyl, benzyl, 3 |
---|
260 | 265 | | naphthyl, adamantyl, cyclopropyl, or propionaldehyde group; 4 |
---|
261 | 266 | | whether or not the compound is further modified to any extent 5 |
---|
262 | 267 | | in the following ways: (i) substitution to the indazole ring to 6 |
---|
263 | 268 | | any extent, (ii) substitution to the phenyl, benzyl, naphthyl, 7 |
---|
264 | 269 | | adamantyl, cyclopropyl, or propionaldehyde group to any 8 |
---|
265 | 270 | | extent, (iii) a nitrogen heterocyclic analog of the indazole ring, 9 |
---|
266 | 271 | | or (iv) a nitrogen heterocyclic analog of the phenyl, benzyl, 10 |
---|
267 | 272 | | naphthyl, adamantyl, or cyclopropyl ring. Substances in this 11 |
---|
268 | 273 | | class include, but are not limited to: ADB-BUTINAATA, 12 |
---|
269 | 274 | | ADB-FUBINAATA. 13 |
---|
270 | 275 | | v. Pyrazoles. Any compound structurally derived from 1H-pyrazole 14 |
---|
271 | 276 | | substituted in all of the following ways: 15 |
---|
272 | 277 | | 1. At the 1 position of the pyrazole ring by an alkyl, haloalkyl, or 16 |
---|
273 | 278 | | alkenyl group. 17 |
---|
274 | 279 | | 2. At the 3 position of the pyrazole ring by a halo benzyl or 18 |
---|
275 | 280 | | propionaldehyde group. 19 |
---|
276 | 281 | | 3. At the 5 position of the pyrazole ring by a halo benzyl or 20 |
---|
277 | 282 | | propionaldehyde group; whether or not the compound is 21 |
---|
278 | 283 | | further modified by a substitution to the propionaldehyde 22 |
---|
279 | 284 | | group to any extent. Substances in this class include, but are 23 |
---|
280 | 285 | | not limited to: 3,5 -ADB-4en-PFUPPYCA, 24 |
---|
281 | 286 | | 5-fluoro-3,5-AB-PFUPPYCA." 25 |
---|
282 | 287 | | SECTION 1.(h) G.S. 90-90(2)h1. reads as rewritten: 26 |
---|
283 | 288 | | "h1. Fentanyl immediate precursor chemical, 27 |
---|
284 | 289 | | 4-anilino-N-phenethyl-4-piperidine 28 |
---|
285 | 290 | | (ANPP).4-anilino-N-phenethylpiperdine (ANPP)." 29 |
---|
286 | 291 | | SECTION 1.(i) G.S. 90-91(k)11. reads as rewritten: 30 |
---|
287 | 292 | | "11. Dehydrochlormethyltestosterone,Dehydrochloromethyltestosterone," 31 |
---|
288 | 293 | | SECTION 1.(j) G.S. 90-91(k)16. reads as rewritten: 32 |
---|
289 | 294 | | "16. Mesterolene,Mesterolone," 33 |
---|
290 | 295 | | SECTION 2. This act is effective when it becomes law. 34 |
---|